Quality Compounder

556 tickers in this investment thesis
Ranks this page's recent reports by score.
McGrath RentCorp
MGRC·Industrials
B ★★★Hold
Current$118.28
Target$133.00
Return+12.4%
Oct 31, 2026

McGrath combines durable rental income, a long dividend-growth record, and expanding electronic test equipment demand, but elevated fleet investment and cyclical modular markets constrain near-term free cash flow.

Score
71
WEX Inc.
WEX·Technology
B ★★★Hold
Current$184.61
Target$207.00
Return+12.1%
Oct 31, 2026

WEX combines embedded commercial payments, improving margins, and shareholder-friendly buybacks with a modest earnings valuation, but weak organic growth and volatile cash conversion limit the near-term upside case.

Score
73
Labcorp Holdings Inc.
LH·Healthcare
B ★★★Hold
Current$361.39
Target$391.20
Return+8.2%
Oct 31, 2026

Labcorp benefits from a durable national diagnostics network, recurring healthcare demand, and growing specialty testing, but premium valuation, reimbursement pressure, and acquisition execution risks constrain prospective returns.

Score
69
Honeywell Aerospace Inc.
HONA·Industrials
B ★★★Hold
Current$154.15
Target$184.80
Return+19.9%
Oct 31, 2026

Honeywell Aerospace's certified aircraft systems, recurring aftermarket demand, and expanding backlog support long-term earnings recovery, but persistent supplier bottlenecks and elevated post-spin-off leverage constrain near-term returns.

Score
69
Carlisle Companies Incorporated
CSL·Industrials
A ★★★★Buy
Current$376.31
Target$432.00
Return+14.8%
Oct 31, 2026

Carlisle combines a high-ROIC commercial roofing franchise with resilient replacement demand and significant share repurchases, but petroleum-based input inflation and construction weakness could delay margin recovery.

Score
81
Fortive Corporation
FTV·Technology
A ★★★★Buy
Current$65.23
Target$69.51
Return+6.6%
Oct 31, 2026

Fortive combines durable industrial technology franchises, strong free cash flow, and aggressive buybacks with improving earnings momentum, although healthcare margin pressure and a relatively full valuation constrain near-term upside.

Score
75
Fomento Económico Mexicano, S.A.B. de C.V.
FMX·Consumer Staples
A ★★★★Buy
Current$126.10
Target$136.40
Return+8.2%
Oct 31, 2026

FEMSA combines OXXO's dominant convenience-store network and Coca-Cola FEMSA's cash-generative bottling operations with attractive cash-flow valuation, although weak European and pharmacy margins could limit consolidated earnings growth.

Score
83
O'Reilly Automotive, Inc.
ORLY·Consumer Discretionary
B ★★★Hold
Current$88.12
Target$98.80
Return+12.1%
Oct 31, 2026

O'Reilly combines a durable automotive aftermarket distribution moat, exceptional returns on capital, and consistent earnings growth, but its premium valuation and leveraged repurchase strategy limit the margin of safety.

Score
71
Aon plc
AON·Financials
A ★★★★Buy
Current$321.67
Target$360.00
Return+11.9%
Oct 31, 2026

Aon's durable global insurance brokerage franchise offers attractive long-term earnings compounding at a moderate valuation, although the $17B USI acquisition introduces substantial integration and leverage risks.

Score
83
KLA Corporation
KLAC·Technology
A ★★★★Buy
Current$157.91
Target$172.20
Return+9.1%
Oct 31, 2026

KLA's dominant semiconductor process-control franchise offers exceptional profitability and durable growth from increasing chip complexity, although cyclical equipment demand and demanding valuation expectations constrain the margin of safety.

Score
78
Microsoft Corporation
MSFT·Technology
A ★★★★Buy
Current$521.91
Target$580.50
Return+11.2%
Oct 31, 2026

Microsoft combines a powerful enterprise software moat with accelerating cloud and AI demand, but unprecedented infrastructure spending makes future free cash flow recovery the central investment challenge.

Score
78